218 related articles for article (PubMed ID: 29516288)
1. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
[TBL] [Abstract][Full Text] [Related]
2. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
3. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.
Wang T; Chen X; Qiao W; Kong L; Sun D; Li Z
BMC Cancer; 2017 Nov; 17(1):719. PubMed ID: 29115924
[TBL] [Abstract][Full Text] [Related]
7. ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.
DaSilva-Arnold SC; Kuo CY; Davra V; Remache Y; Kim PCW; Fisher JP; Zamudio S; Al-Khan A; Birge RB; Illsley NP
Mol Hum Reprod; 2019 Feb; 25(2):61-75. PubMed ID: 30462321
[TBL] [Abstract][Full Text] [Related]
8. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression].
Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T
Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392
[TBL] [Abstract][Full Text] [Related]
10. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
11. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
12. GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells.
Raghu D; Mobley RJ; Shendy NAM; Perry CH; Abell AN
Cell Rep; 2019 Mar; 26(13):3684-3697.e7. PubMed ID: 30917321
[TBL] [Abstract][Full Text] [Related]
13. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger E‑box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma.
Li Q; Ma L; Wu Z; Wang G; Huang Q; Shen Z; Yu R
Mol Med Rep; 2019 Jun; 19(6):4545-4552. PubMed ID: 30957184
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
16. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
[TBL] [Abstract][Full Text] [Related]
17. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial-mesenchymal transition in diabetes.
de Jesus DS; Mak TCS; Wang YF; von Ohlen Y; Bai Y; Kane E; Chabosseau P; Chahrour CM; Distaso W; Salem V; Tomas A; Stoffel M; Rutter GA; Latreille M
Mol Metab; 2021 Nov; 53():101248. PubMed ID: 33989778
[TBL] [Abstract][Full Text] [Related]
19. ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism.
Burks HE; Matossian MD; Rhodes LV; Phamduy T; Elliott S; Buechlein A; Rusch DB; Miller DFB; Nephew KP; Chrisey D; Collins-Burow BM; Burow ME
Breast Cancer Res Treat; 2021 Aug; 189(1):25-37. PubMed ID: 34231077
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]